Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
UBE2Q2 pseudogene 13 (abbreviated as UBE2Q2P13) is a human pseudogene listed in gene and nomenclature databases[2][3]. Pseudogenes are segments of DNA that resemble known genes but typically lack the ability to encode a functional protein. UBE2Q2P13 shares sequence similarity with the coding gene UBE2Q2, which encodes a ubiquitin-conjugating enzyme E2 (E2 enzyme), but UBE2Q2P13 itself is not believed to be expressed as a functional protein and has no recognized molecular, cellular, or therapeutic role[2][3]. There are multiple UBE2Q2 pseudogenes in the human genome, typically appearing in sequence analyses as non-coding entries. No information suggests this pseudogene has relevance as a drug target, biomarker, or mechanistic role in disease. UBE2Q2 pseudogene 13 (UBE2Q2P13) is a non-coding, non-functional pseudogene; it is **not** a therapeutic target and does **not** encode a protein involved in any recognized biological or disease processes[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on UBE2Q2 pseudogene 13 (UBE2Q2P13).